Integral Ad Science Earns Prestigious Webby Finalist Nomination for its Generative AI Innovation, IAS Agent
Kamelia Aryafar Joins Integral Ad Science (IAS) Board of Directors
Kamelia Ayrafar Joins Integral Ad Science (IAS) Board of Directors
Head to Head Analysis: TechTarget (NASDAQ:TTGT) versus Integral Ad Science (NASDAQ:IAS)
Integral Ad Science Holding Corp. (NASDAQ:IAS) Given Consensus Recommendation of “Hold” by Analysts
Adaptive Medias (OTCMKTS:ADTM) & Integral Ad Science (NASDAQ:IAS) Head-To-Head Review
IAS APPOINTS MELISSA FURZE AS HEAD OF DATA SCIENCE
Integral Ad Science Holding Corp. (NASDAQ:IAS) Receives Average Recommendation of “Hold” from Brokerages
IAS LAUNCHES 'IAS AGENT' ENABLING MARKETERS TO SURFACE DEEP CAMPAIGN INSIGHTS IN REAL-TIME AND INCREASE AD PERFORMANCE
Media Experts Redefine What Quality Means in AI World Dominated by Social Media and Digital Video, According to New IAS Industry Pulse Report
Investor Cuts $12.9 Million Stake as IAS Heads Toward $1.9 Billion Buyout
Integral Ad Science Holding Corp. $IAS Stock Position Raised by Geode Capital Management LLC
Campbell & CO Investment Adviser LLC Buys New Holdings in Integral Ad Science Holding Corp. $IAS
INTEGRAL AD SCIENCE EARNS MRC ACCREDITATION FOR REPORTING OF IMPRESSIONS, VIEWABILITY AND INVALID TRAFFIC ON AMAZON PROPERTIES
Integral Ad Science (IAS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Integral Ad Science (IAS) Q3 Earnings Miss Estimates
IAS Reports Third Quarter 2025 Financial Results
IAS and Snap Announce Expansion of Measurement Partnership to Validate Ad Effectiveness in Sponsored Snaps
Cwm LLC Increases Stake in Integral Ad Science Holding Corp. $IAS
TikTok Selects IAS for Brand Safety Measurement for TikTok Pangle Advertisers
Kaskela Law LLC Investigates Fairness of Proposed $10.30 Per Share Buyout of Integral Ad Science (Nasdaq: IAS) Stockholders and Encourages Investors to Contact the Firm
IAS LAUNCHES FIRST AI-DRIVEN, INDEPENDENT BRAND SAFETY AND SUITABILITY MEASUREMENT FOR META THREADS
Kaskela Law LLC is Investigating the Fairness of the Integral Ad Science (IAS) $10.30 Per Share Buyout Agreement and Encourages Investors to Contact the Firm to Discuss Their Options
IAS STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Integral Ad Science (Nasdaq: IAS) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Integral Ad Science Holding Corp. (NASDAQ: IAS)
Integral Ad Science (IAS) Surges 20.5%: Is This an Indication of Further Gains?
Shareholder Alert: The Ademi Firm investigates whether Integral Ad Science is obtaining a Fair Price for its Public Shareholders
Johnson Fistel, PLLP Assessing Board Fiduciary Duty Breaches in the IAS Go-Private Merger
Private equity firm Novacap to buy Integral Ad Science in $1.9 billion deal
IAS to be Acquired by Novacap for $1.9 Billion to Further Support Its Strategic Goals
IAS and Good-Loop Announce Enhanced Emissions Measurement Offering to Empower All Advertisers to Further Measure and Reduce Environmental Impact
The Bears Are Wrong About Integral Ad Science
Is Integral Ad Science (IAS) a Solid Growth Stock? 3 Reasons to Think "Yes"
Wall Street Analysts Think Integral Ad Science (IAS) Could Surge 50.06%: Read This Before Placing a Bet
Why Integral Ad Science (IAS) Might be Well Poised for a Surge
Integral Ad Science (IAS) is an Incredible Growth Stock: 3 Reasons Why
Wall Street Analysts Believe Integral Ad Science (IAS) Could Rally 48.33%: Here's is How to Trade
Why Integral Ad Science's Stock Crushed the Market on Friday
Integral Ad Science Holding Corp. (IAS) Q2 2025 Earnings Call Transcript
Here's What Key Metrics Tell Us About Integral Ad Science (IAS) Q2 Earnings
Integral Ad Science (IAS) Q2 Earnings and Revenues Beat Estimates
IAS (IAS) Earnings Jump 16%
IAS Reports Second Quarter 2025 Financial Results
IAS to Participate at Upcoming Investor Conference
Integral Ad Science Receives Industry's First Ethical AI Certification from Alliance for Audited Media (AAM)
Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025
IAS to Announce Second Quarter 2025 Financial Results on August 7, 2025
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
IAS Launches First-to-Market AI-Powered Social Attention Measurement for Snap
IAS Announces Completion of Expanded Credit Facility